← FDA Drug Approvals (Drugs@FDA)

EXCEDRIN (MIGRAINE RELIEF)

NDA · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 1998-01-14

Drug application

FDA Application #

NDA020802

Application type

New Drug Application

Brand name

EXCEDRIN (MIGRAINE RELIEF)

Generic name

ACETAMINOPHEN, ASPRIN, CAFFEINE

Active ingredients

ACETAMINOPHEN; ASPIRIN; CAFFEINE

Dosage form

TABLET

Route

ORAL

Marketing status

Over-the-counter

Sponsor

HALEON US HOLDINGS

Manufacturer

Haleon US Holdings LLC

First approval

1998-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown